ATE528651T1 - Diagnoseverfahren für pulmonale arterielle hypertonie - Google Patents
Diagnoseverfahren für pulmonale arterielle hypertonieInfo
- Publication number
- ATE528651T1 ATE528651T1 AT09742310T AT09742310T ATE528651T1 AT E528651 T1 ATE528651 T1 AT E528651T1 AT 09742310 T AT09742310 T AT 09742310T AT 09742310 T AT09742310 T AT 09742310T AT E528651 T1 ATE528651 T1 AT E528651T1
- Authority
- AT
- Austria
- Prior art keywords
- arterial hypertension
- pulmonary arterial
- diagnostic methods
- paht
- tenascin
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/321—Arterial hypertension
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0852459A FR2930036B1 (fr) | 2008-04-11 | 2008-04-11 | Procede de diagnostic d'une hypertension arterielle pulmonaire. |
PCT/FR2009/050661 WO2009136112A1 (fr) | 2008-04-11 | 2009-04-10 | Procede de diagnostic d'une hypertension arterielle pulmonaire |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE528651T1 true ATE528651T1 (de) | 2011-10-15 |
Family
ID=39876870
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09742310T ATE528651T1 (de) | 2008-04-11 | 2009-04-10 | Diagnoseverfahren für pulmonale arterielle hypertonie |
Country Status (10)
Country | Link |
---|---|
US (1) | US8609356B2 (de) |
EP (1) | EP2274623B1 (de) |
JP (1) | JP5518836B2 (de) |
AT (1) | ATE528651T1 (de) |
CA (1) | CA2721049C (de) |
DK (1) | DK2274623T3 (de) |
ES (1) | ES2376459T3 (de) |
FR (1) | FR2930036B1 (de) |
PT (1) | PT2274623E (de) |
WO (1) | WO2009136112A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2964314B1 (fr) * | 2010-09-02 | 2013-06-28 | Assist Publ Hopitaux De Paris | Score predictif du risque de survenue d'hypertension arterielle pulmonaire chez des patients atteints de sclerodermie systemique. |
KR20140109956A (ko) * | 2011-12-12 | 2014-09-16 | 아이시스 이노베이션 리미티드 | 테나신-c 및 류마티스 관절염에서의 이의 용도 |
WO2014067965A1 (en) * | 2012-10-29 | 2014-05-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Methods of predicting or diagnosing a pulmonary arterial hypertension |
WO2014089017A1 (en) * | 2012-12-03 | 2014-06-12 | Vascular Biosciences | Methods for increasing the selective efficacy of gene therapy using car peptide and heparan-sulfate mediated macropinocytosis |
JP6116938B2 (ja) * | 2013-02-28 | 2017-04-19 | 学校法人順天堂 | 新規な肺高血圧症のマーカー |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880750A (en) * | 1987-07-09 | 1989-11-14 | Miragen, Inc. | Individual-specific antibody identification methods |
WO1999043308A2 (en) * | 1998-02-27 | 1999-09-02 | Marlene Rabinovitch | Treating pulmonary hypertension through tenascin suppression and elastase inhibition |
DE19939575C1 (de) * | 1999-08-20 | 2001-08-02 | Orgentec Diagnostika Gmbh | Verfahren zur Diagnose von Sjögren-Syndrom |
JP3646159B2 (ja) * | 2001-02-08 | 2005-05-11 | 国立大学法人三重大学 | 抗テネイシンcモノクローナル抗体及び当該抗体を産生するハイブリドーマ |
US6989276B2 (en) * | 2001-05-10 | 2006-01-24 | Battelle Energy Alliance, Llc | Rapid classification of biological components |
US7438908B2 (en) * | 2002-02-26 | 2008-10-21 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Anti-human tenascin monoclonal antibody |
WO2005009366A2 (en) * | 2003-07-24 | 2005-02-03 | Cornell Research Foundation, Inc. | Restoring vascular function |
US20080026485A1 (en) * | 2006-04-18 | 2008-01-31 | Wolfgang Hueber | Antibody profiling for determination of patient responsiveness |
US20120295797A1 (en) * | 2008-04-02 | 2012-11-22 | Jones Peter L | Methods for diagnosis and prognosis of pulmonary hypertension |
-
2008
- 2008-04-11 FR FR0852459A patent/FR2930036B1/fr not_active Expired - Fee Related
-
2009
- 2009-04-10 EP EP09742310A patent/EP2274623B1/de not_active Not-in-force
- 2009-04-10 ES ES09742310T patent/ES2376459T3/es active Active
- 2009-04-10 CA CA2721049A patent/CA2721049C/fr not_active Expired - Fee Related
- 2009-04-10 WO PCT/FR2009/050661 patent/WO2009136112A1/fr active Application Filing
- 2009-04-10 PT PT09742310T patent/PT2274623E/pt unknown
- 2009-04-10 DK DK09742310.7T patent/DK2274623T3/da active
- 2009-04-10 JP JP2011503488A patent/JP5518836B2/ja not_active Expired - Fee Related
- 2009-04-10 US US12/936,745 patent/US8609356B2/en not_active Expired - Fee Related
- 2009-04-10 AT AT09742310T patent/ATE528651T1/de active
Also Published As
Publication number | Publication date |
---|---|
EP2274623A1 (de) | 2011-01-19 |
JP2011516876A (ja) | 2011-05-26 |
JP5518836B2 (ja) | 2014-06-11 |
FR2930036B1 (fr) | 2010-05-07 |
CA2721049C (fr) | 2016-02-09 |
FR2930036A1 (fr) | 2009-10-16 |
DK2274623T3 (da) | 2012-01-09 |
US20110033876A1 (en) | 2011-02-10 |
CA2721049A1 (fr) | 2009-11-12 |
WO2009136112A1 (fr) | 2009-11-12 |
US8609356B2 (en) | 2013-12-17 |
EP2274623B1 (de) | 2011-10-12 |
PT2274623E (pt) | 2012-01-05 |
ES2376459T3 (es) | 2012-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200801046A1 (ru) | Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro | |
SG10201408392PA (en) | Methods of determining patient response by measurement of her-3 | |
ATE452343T1 (de) | Verbesserte vitamin-d-messung | |
WO2013068374A3 (en) | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment | |
ES2572372T3 (es) | Método de diagnóstico de enfermedades neurodegenerativas basado en la medición de los niveles o de la actividad de SIRT1 | |
MX2014003422A (es) | Método para la monitorización, el diagnostico y/o el pronostico de lesión renal aguda en fase temprana. | |
EP3208617A3 (de) | Lipidomische biomarker zur prognose kardiosvaskulärer ergebnisse bei patienten mit erkrankung der herzkranzgefässe ohne statinbehandlung | |
WO2006113245A3 (en) | Methods for measuring glycan levels of proteins | |
NZ605698A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
ATE471512T1 (de) | Verwendung des proteins s100a 12 als marker für kolorektalkarzinom | |
ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
WO2010046443A3 (en) | Methods for detection and diagnosis of a bone or cartilage disorder | |
ATE528651T1 (de) | Diagnoseverfahren für pulmonale arterielle hypertonie | |
RU2013138721A (ru) | Способы и наборы для прогнозирования риска дыхательной недостаточности, почечной недостаточности или тромбопении у пациента, страдающего сепсисом, путем измерения уровней эндокана в крови | |
NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
ATE474228T1 (de) | Reagenz für hämoglobinabbau | |
ATE500503T1 (de) | Cd86- und cd80-rezeptorkonkurrenztests | |
BR112014009223A2 (pt) | método para o diagnóstico da doença de niemann-pick | |
WO2015077382A3 (en) | Combined cytology and molecular testing for early detection of esophageal adenocarcinoma | |
PE20120592A1 (es) | Metodo con biomarcadores para el seguimiento de un tratamiento | |
WO2010144553A3 (en) | Methods for diagnosing blood vessel reocclusion | |
DE602006011602D1 (de) | Verfahren zur Diagnose einer Erkrankung mit Beteiligung eines Anti-AT1-Rezeptor-Antikörpers | |
WO2009007649A3 (fr) | Dispositif et procede d'identification et de determination de groupes sanguins | |
WO2008131261A3 (en) | Peptide biomarkers of cardiovascular disease | |
EA201400571A1 (ru) | Специфичные к трансресвератролу антитела и их применение |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2274623 Country of ref document: EP |